The MarketWatch News Department was not involved in the creation of this content. -- Study results support advancing SGX945 in this difficult-to-treat orphan disease -- Results suggest potential ...

LONDON--(BUSINESS WIRE)--According to a recent Technavio report, the Behcet's disease therapeutics market is expected to grow by USD 224.55 million during 2019-2023. Growth in the Behcet's disease ...

The Orphan Drug designation was supported by data from an open-label phase 2 trial that included 8 adult patients with mild to moderate Behçet disease and active oral and/or genital ulcers. The Food ...

Please provide your email address to receive an email when new articles are posted on . In a presentation here at the Congress of Clinical Rheumatology, Yazici outlined demographics, diagnostic ...

Please provide your email address to receive an email when new articles are posted on . The rare and complex Behcet’s disease is often misdiagnosed or undiagnosed, leading to significant, but ...

PRINCETON, N.J., Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to ...

An analysis of human genetic and biomarker data found that tuberculosis was a risk factor for Behçet disease, a noninfectious uveitis condition. An analysis of human genetic and biomarker data ...

LONDON--(BUSINESS WIRE)--Technavio has announced their latest pipeline analysis report on the Behcet's syndrome market. The report includes a detailed analysis of the pipeline molecules under ...

Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet syndrome, with adalimumab demonstrating a quicker response time; both drugs ...

Behçet's Disease is a rare, chronic, systemic vasculitis and an autoimmune condition in which the body’s immune system ...

Behçet's disease is a complex, multisystem inflammatory disorder characterised by recurrent mucocutaneous lesions, ocular involvement, and vascular, neurological, and gastrointestinal manifestations.